Abbott Shares Rise on Second-Quarter Beat, Increased Guidance

Healthy earnings sent Abbott Laboratories (ABT) shares higher Wednesday, July 18.

The stock was up 2.7% to $64.58 in early trading after the healthcare company unveiled second-quarter results that exceeded expectations and increased its outlook.

The Abbott Park, Ill., company reported adjusted diluted earnings per share of 73 cents, up 17.7% from the year-ago period. Revenue rose 17% on a reported basis from 2017 to $7.8 billion.

Analysts expected, on average, adjusted EPS of 71 cents on $7.71 billion in revenue, according to FactSet Research Systems Inc.

"We forecast continued strong performance and are raising our full-year outlook despite recent currency shifts," Abbott chairman and CEO Miles D. White said in a statement.

For full-year 2018, Abbott now expects diluted EPS from continuing operations on a GAAP basis of $1.34 to $1.40, compared with the previous guidance of $1.23 to $1.33, and adjusted diluted EPS of $2.85 to $2.91, compared with the prior forecast of $2.80 to $2.90.

Abbott is a holding in Jim Cramer's Action Alerts PLUS member club. Want to be alerted before Jim Cramer buys or sells AAPL or GOOGL? Learn more now.

More from Investing

Data Regulation on FAANG's Could Just Be Underway: Cramer's Investing Teach-in

Data Regulation on FAANG's Could Just Be Underway: Cramer's Investing Teach-in

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

3 Things Investors Can Do to Stay Strategic When the Market's Volatile

How to Be a Tactical Investor in the Current Market

How to Be a Tactical Investor in the Current Market

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors

Canopy Growth CEO: Here's What the Future of Cannabis Looks Like for Investors

A Guide to Investing in the Fast-Emerging Cannabis Industry

A Guide to Investing in the Fast-Emerging Cannabis Industry